3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and budipine

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with budipine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klockgether, T; Löschmann, PA; Petersen, V; Steinbach, JP; Turski, L; Wüllner, U1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and budipine

ArticleYear
Effects of the antiparkinsonian drug budipine on central neurotransmitter systems.
    European journal of pharmacology, 1996, Apr-22, Volume: 301, Issue:1-3

    Topics: Animals; Antiparkinson Agents; Biperiden; Central Nervous System; Dopamine; Excitatory Amino Acid Antagonists; Male; Mice; Microdialysis; Muscarinic Antagonists; N-Methylaspartate; Neostriatum; Neurotransmitter Agents; Oxidopamine; Piperazines; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Rotation; Seizures; Stereotyped Behavior; Sympatholytics

1996